<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151320">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01866189</url>
  </required_header>
  <id_info>
    <org_study_id>11 252 01</org_study_id>
    <nct_id>NCT01866189</nct_id>
  </id_info>
  <brief_title>Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke</brief_title>
  <acronym>STROKE F-MISO</acronym>
  <official_title>Assessment of Hypoxic Tissues in Acute Ischemic Stroke With 18F-FMISOnidazole PET and Comparison With MRI : A Prospective Multicenter Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <authority>France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a French multicenter prospective study including 5 stroke units with available
      MRI and F-MISO PET for patients with acute ischemic stroke.

      Background and Purpose: 18F-Fluoromisonidazole (FMISO) PET has been used to identify hypoxic
      tissues in animals and stroke patients. While MRI has become the gold standard acute stroke
      imaging, no published study has compared FMISO PET and MRI.

      The aim of this prospective study is to identify hypoxic tissues in 40 patients with acute
      ischemic stroke with F-MISO PET and to compare the location and the outcome of these hypoxic
      cells with MRI datas (weighted diffusion and FLAIR) and to clinical outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      40 prospective patients (aged 18 to 85 years) will be included in the first 36 hours after
      ischemic stroke onset.

      The study period will be 2 years. Included patients will have F-MISO PET followed by brain
      MRI (MRI-1)(diffusion, FLAIR, perfusion, TOF) as soon as possible after stroke onset (less
      than 36 hours). A second brain MRI (MRI-2) will be performed on day 7.

      The aim of the study is to locate hypoxic tissues and to compare with ischemic tissues
      defined by diffusion and FLAIR MRI sequences, with MRI evolution, and with clinical status
      at day 7 and day 90.

      Inclusion criterias

        -  Patients aged 18-85 years with encephalic brain ischemic stroke,

        -  defined stroke onset,

        -  NIHSS 5 to 20,

        -  F-MISO Pet and MRI available &lt;36 hours after stroke onset,
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>volume and location of F-MISO uptake in stroke patients</measure>
    <time_frame>acute phase of brain ischemia &lt; 36 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>comparison of F-MISO uptake areas and ischemic lesions defined by weighted diffusion and FLAIR on</measure>
    <time_frame>acute phase of brain ischemia &lt; 36 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>PET and MRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Included patients will have F-MISO PET followed by brain MRI (MRI-1)(diffusion, FLAIR, perfusion, TOF) as soon as possible after stroke onset (less than 36 hours). A second brain MRI (MRI-2) will be performed on day 7.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>TEP and MRI</intervention_name>
    <arm_group_label>PET and MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18-85 years with encephalic brain ischemic stroke,

          -  defined stroke onset,

          -  NIHSS 5 to 20,

          -  F-MISO Pet and MRI available &lt;36 hours after stroke onset,

          -  Written consent signed by patient or family

        Exclusion Criteria:

          -  contraindication to MRI

          -  comatous status

          -  5 &lt; NIHSS &gt; 20

          -  non ischemic stroke

          -  brainstem stroke
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-François Albucher, MD</last_name>
    <phone>05 61 77 76 40</phone>
    <email>albucher.jf@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>François Chollet, MD</last_name>
    <phone>05 61 77 76 40</phone>
    <email>chollet.f@chu-toulouse.fr</email>
  </overall_contact_backup>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 18, 2013</lastchanged_date>
  <firstreceived_date>May 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ischemic stroke</keyword>
  <keyword>hypoxic tissues</keyword>
  <keyword>F-MISO uptake</keyword>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>F-MISO Positon Emission Tomography</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
